Jazz Pharmaceuticals plc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $-72.8M | $15.6M |
| FY2010 | — | $30.6M | $44.8M |
| FY2011 | $0 | $192.8M | $82.1M |
| FY2012 | $427.1M | $1.12B | $387.2M |
| FY2013 | $544.4M | $1.30B | $636.5M |
| FY2014 | $1.33B | $1.37B | $684.0M |
| FY2015 | $1.15B | $1.60B | $988.8M |
| FY2016 | $1.99B | $1.88B | $366.0M |
| FY2017 | $1.54B | $2.71B | $386.0M |
| FY2018 | $1.56B | $2.76B | $309.6M |
| FY2019 | $1.57B | $3.11B | $637.3M |
| FY2020 | $1.85B | $3.66B | $1.06B |
| FY2021 | $6.02B | $3.97B | $591.4M |
| FY2022 | $5.69B | $3.09B | $881.5M |
| FY2023 | $5.11B | $3.74B | $1.51B |
| FY2024 | $6.08B | $4.09B | $2.41B |
| FY2025 | $4.33B | $4.32B | $1.39B |